Skip to content

Injection site rotation

Tap where you injected. The map numbers your last three sites, lists the ones you used longest ago, and keeps it all on your device.

Where did you inject?

  • 2 in (5 cm) around the navel
SiteTap the map

Saved on this device only. Nothing is sent to Peptinote.

Your sites

Tap where you injected, then save. Your last three sites get a number on the map, newest first, so you can see at a glance where you’ve been.

This is arithmetic, not medical advice. Confirm with your prescriber or pharmacist.

The map shows your own history, not where to inject next. Use only the sites your medicine’s label or your prescriber allows.

Log doses and sites in the trackerFree, private, stays on your phone.

Clear your site history?

This deletes the 0 sites you saved with this map on this device. You can't undo it.

How to use the rotation map

  1. Tap where you injected

    Choose the area on the map: one of four squares around the belly button, a thigh, an upper arm or, on the back view, a buttock. Left and right are your own.

  2. Save it

    The day is today unless you change it. The site is saved in your browser on this device, and nothing is sent to us.

  3. Look before your next injection

    Your last three sites are numbered on the map, newest first, and the list shows the sites you used longest ago. Inject where your label and prescriber allow.

Why rotate injection sites

Injecting the same spot again and again can cause lipohypertrophy: a build-up of fatty tissue under the skin that you may not see but can often feel as a soft or firm lump. The best evidence comes from insulin.

  • Among 430 people injecting insulin, 64% had lipohypertrophy, and it was strongly linked to not rotating sites. Of those who rotated correctly, only 5% had it (Blanco et al., 2013).
  • Insulin injected into these lumps was absorbed less, and far less predictably, than insulin injected into normal tissue (Famulla et al., 2016).
  • International recommendations say not to inject into these areas, and that correct site rotation helps prevent them (Frid et al., 2016).

GLP-1 labels say the same in their own words. Mounjaro’s and Zepbound’s instructions ask you to rotate within the area you choose “to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps)” (Mounjaro, Zepbound).

Where the labels say to inject

The FDA-approved labels for Ozempic, Wegovy, Mounjaro and Zepbound list the same three areas, under the skin:

  • Stomach (abdomen), at least 2 inches (5 cm) from the belly button (Wegovy, Zepbound). That’s the dashed ring on the map.
  • Thigh, the front of the thigh in Wegovy’s instructions; MedlinePlus says the outer side of the upper thigh (MedlinePlus).
  • Upper arm. Mounjaro and Zepbound name the back of the upper arm, and say another person should give the injection there.

Rotate every time. Each label says to change the site with each injection: you can stay in the same area, but use a different spot (Ozempic, Mounjaro). MedlinePlus adds at least 1 inch between sites.

Skip damaged skin. Don’t inject where the skin is tender, bruised, red, scaly or hard, into scars, or where it has pits, is thickened or has lumps (Wegovy, Zepbound).

Buttocks appear in insulin guidance (Embecta) but on none of these four GLP-1 labels. They’re on the map for people whose prescriber uses them. Your product’s label is the rule.

How the map works

The map only shows your own history. The site you saved last gets a 1, the one before it a 2, then a 3; any other site you’ve used is shaded lightly. The list beside the map puts the sites you used longest ago first. It never tells you where to inject next.

The front view faces you, so your right side is on the left of the screen; the labels under each view say which side is which. Upper arms show on both views and count as one site.

Your sites are saved in this browser, on this device, and nothing is sent to Peptinote. Sites you log with a dose in the tracker show here too. Undo removes the last site you saved here, and Clear history deletes them all.

Sources

  1. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetesBlanco M, et al. Diabetes Metab, 2013 · Accessed Oct 16, 2026 (opens in a new tab)
  2. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose controlFamulla S, et al. Diabetes Care, 2016 · Accessed Oct 16, 2026 (opens in a new tab)
  3. New insulin delivery recommendationsFrid AH, et al. Mayo Clin Proc, 2016 · Accessed Oct 16, 2026 (opens in a new tab)
  4. MOUNJARO (tirzepatide) injection: prescribing information, medication guide and instructions for useEli Lilly and Company, via DailyMed (U.S. National Library of Medicine), 2026 · Accessed Oct 16, 2026 (opens in a new tab)
  5. ZEPBOUND (tirzepatide) injection: prescribing information, medication guide and instructions for useEli Lilly and Company, via DailyMed (U.S. National Library of Medicine), 2026 · Accessed Oct 16, 2026 (opens in a new tab)
  6. WEGOVY (semaglutide) injection: prescribing information, medication guide and instructions for useNovo Nordisk, via DailyMed (U.S. National Library of Medicine), 2026 · Accessed Oct 16, 2026 (opens in a new tab)
  7. OZEMPIC (semaglutide) injection: prescribing information and medication guideNovo Nordisk, via DailyMed (U.S. National Library of Medicine), 2026 · Accessed Oct 16, 2026 (opens in a new tab)
  8. Subcutaneous (SQ) injectionsMedlinePlus, U.S. National Library of Medicine, 2025 · Accessed Oct 16, 2026 (opens in a new tab)
  9. Injection technique guideEmbecta Corp., 2025 · Accessed Oct 16, 2026 (opens in a new tab)

Questions people ask

Where do you inject Mounjaro or Zepbound?

Under the skin of your stomach (abdomen) or thigh, or the back of your upper arm if another person gives the injection. The instructions for use say to keep at least 2 inches from the belly button and to change (rotate) the injection site each week: you may use the same area, but choose a different spot in it (Mounjaro, Zepbound).

Where do you inject Wegovy or Ozempic?

In the stomach (abdomen), thigh or upper arm. Wegovy’s instructions say to keep 2 inches (5 cm) from your belly button, and both labels say to rotate the injection site with each injection (Wegovy, Ozempic).

Does the injection site change how well it works?

For semaglutide and tirzepatide, the FDA labels say similar exposure was achieved with injections in the abdomen, thigh or upper arm (Wegovy, Zepbound). For other medicines, ask your pharmacist.

How far apart should injection sites be?

MedlinePlus says to change the site from one injection to the next, at least 1 inch apart, and to stay at least 2 inches from the belly button (MedlinePlus). Embecta’s insulin guide suggests at least a finger’s width from the last injection (Embecta). Your product’s own instructions come first.

Where should I inject peptides?

Wherever your product’s label or your prescriber says. Products that aren’t FDA-approved have no approved instructions, so Peptinote doesn’t give injection instructions for them. Our guide to subcutaneous injection sites covers the general technique, with sources.

Is my injection site history private?

Yes. The sites you save stay in your browser’s storage on this device; nothing is sent to Peptinote, and there’s no account. Clearing your browser’s site data deletes them. To keep sites with your doses, use the free tracker, which also stays on your device.

Medical review in progressLast reviewed

Every result is plain arithmetic from formulas we publish in full and check with automated tests. Peptinote doesn’t suggest doses and never sells or links to sellers of peptides.